Get Crysvita (burosumab) Covered by Cigna in Illinois: Complete Prior Authorization and Appeals Guide
Answer Box: Getting Crysvita Covered by Cigna in Illinois
Eligibility: Crysvita (burosumab) requires prior authorization from Cigna for X-linked hypophosphatemia (XLH) or tumor-induced osteomalacia (TIO). Fastest path: Have your specialist submit the Cigna Crysvita CCRD Prior Authorization Form with genetic testing (XLH) or tumor documentation (TIO), baseline fasting serum phosphorus